Rate My Professor Ramzi Salloum

Salloum has authored more than 180 peer-reviewed publications in cancer prevention and control. Key works include 'Expansion of Guideline-Recommended Lung Cancer Screening Eligibility: Implications for Health Equity of Joint Screening and Cessation Interventions' in the Journal of Thoracic Oncology (2022), 'How Smokers of Menthol Cigarettes and Flavored Cigars Might Respond to FDA's Proposed Bans' in Nicotine & Tobacco Research (2022), 'Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes' in Preventive Medicine Reports (2022), and 'Marijuana use among US adults with cancer: findings from the 2018-2019 Behavioral Risk Factor Surveillance System' in the Journal of Cancer Survivorship (2022). His research has been funded by the National Institutes of Health, Patient-Centered Outcomes Research Institute, Cancer Research UK, International Development Research Centre, Florida Department of Health, and Aetna Foundation. Salloum has testified before the Alachua County Commission, contributing to an ordinance raising the tobacco purchase age to 21 statewide. He serves as faculty for the National Cancer Institute’s Training Institute for Dissemination and Implementation Research in Cancer, co-chairs the Society for Research on Nicotine and Tobacco’s Global Research Network, has received three NCI-supported fellowships and the 2022 Outstanding Specialist Award from the Florida Extension Association of Family and Consumer Sciences, was elected vice chair of the Florida Cancer Control and Research Advisory Council, and appointed to an NIH study section for implementation science.